API SUPPLIERS

API Suppliers

59

US DMFs Filed

40

CEP/COS Certifications

20

JDMFs Filed

0

Other Certificates

11

Other Suppliers

16

API REF. PRICE (USD / KG)

139

API Market Place

23

INTERMEDIATES

1

DOSSIERS // FDF

USA (Orange Book)

34

Europe

113

Canada

5

Australia

0

South Africa

8

Uploaded Dossiers

56

GLOBAL SALES (USD Million)

U.S. Medicaid

265.00

Annual Reports

0

FDF Market Place

30

EXCIPIENTS

243

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

1

News

11

REF STANDARD

EDQM

1

USP

3

JP

0

Other Listed Suppliers

5

SERVICES

2

Full Screen View

Reset Filter

Price Info

USP

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Cefuroxime Axetil E-isomers (15 mg) (1RS,6R,7R)-1-Aceto...

PDF Supplier PDF

URL Supplier Web Content

Catalog Number

1098253

CAS Number

97232-96-7

Current Lot

F034U0

Previous Lot

NDC Code

Unit Price

715

Special Restriction

ASK
US

Upload
your Marketing & Sales content

USP

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Cefuroxime Axetil Delta-3-Isomers (10 mg) ((1RS,6R,7R)-...

PDF Supplier PDF

URL Supplier Web Content

Catalog Number

1098231

CAS Number

N/A

Current Lot

R04630

Previous Lot

J0K016 (30-SEP-2017)

NDC Code

Unit Price

730

Special Restriction

ASK
US

Upload
your Marketing & Sales content

USP

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Cefuroxime Axetil (350 mg)

PDF Supplier PDF

URL Supplier Web Content

Catalog Number

1098220

CAS Number

64544-07-6

Current Lot

R011M0

Previous Lot

H0K039 (30-SEP-2015)

NDC Code

Unit Price

230

Special Restriction

ASK
US

Upload
your Marketing & Sales content

List of USP Standards of Cefuroxime on PharmaCompass.com.

Cefuroxime

Cefuroxime

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

59 API Suppliers

40 USDMF

20 CEP/COS

11 EU WC

24 KDMF

4 NDC API

16 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Formulations

216 Dossiers

34 FDA Orange Book

113 Europe

5 Canada

8 South Africa

56 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SUSPENSION;ORAL - EQ 125MG BASE/5ML

FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML

RELATED EXCIPIENT COMPANIES

Suppliers

20 Roquette

19 SPI Pharma

19 BASF

17 Kerry

14 Seppic

14 Microlex e.U

12 Corel Pharma Chem

10 Sigachi Industries

10 Gangwal Healthcare

9 Gangwal Chemicals

9 Ideal Cures Pvt Ltd

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Actylis

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Lonza Capsugel

4 DKSH

4 Ingredion Pharma Solutions

4 Nanjing Well Pharmaceutical

4 Vasa Pharmachem

4 Rochem International Inc

3 Prachin Chemical

3 Boai NKY Pharmaceuticals Ltd

3 DFE Pharma

3 Kima Chemical

2 Clariant

2 Seqens

2 Finar

2 Pfanstiehl

2 Jai Radhe Sales

2 Nomisma Healthcare

2 The Dow Chemical Company

2 Aeon Procare

1 Shijiazhuang Huaxu Pharmaceutical

1 Evonik

1 Shanghai Welltone Material Technology Co., Ltd

1 Alcedo Pharmachem

1 Vertellus

1 Ulanqab Kema New Material

1 Nanjing Bold Chemical

1 ACG Worldwide

1 Avesta Pharma

1 Pharmatrans-Sanaq

TABLET;ORAL - EQ 125MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 250MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 500MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons